ReviewPituitary2003
Radiotherapy for non-functioning pituitary tumors--when and under what circumstances?
Review in Pituitary, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 52 citations in OpenAlex.
- Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.Diagnostics (Basel, Switzerland) · 2022Review
- Long-term results of Gamma Knife Radiosurgery for Postsurgical residual or recurrent nonfunctioning Pituitary Adenomas.International journal of medical sciences · 2020Article
- Different Volumetric Measurement Methods for Pituitary Adenomas and Their Crucial Clinical Significance.Scientific reports · 2017Article
- Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System.Brain tumor research and treatment · 2016Article
- The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study.Neuro-oncology practice · 2014Article
- The role of radiation therapy in the management of non-functioning pituitary adenomas.Journal of endocrinological investigation · 2011Review
- Radiotherapy of nonfunctioning and gonadotroph adenomas.Pituitary · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of pituitary radiotherapy (RT) in the management of clinically non-functioning pituitary tumors (NFTs) remains controversial. Observational studies suggest that RT is effective in preventing the regrowth of NFT remnants following initial surgical debulking. However, not all tumor remnants will regrow in the absence of pituitary RT. Furthermore there are concerns relating to potential complications of pituitary RT, particularly hypopituitarism and its associated excess mortality. In the absence of any clear consensus guidelines relating to the application of pituitary RT in this setting, the following text sets out to review the evidence base for the efficacy of RT in preventing NFT regrowth and attempts to balance this against the potentially deleterious consequences of pituitary RT. A pragmatic approach is adopted with a view to offering clinically relevant guidance for managing patients with postoperative NFT remnants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.